Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants
Clinical trial NCT01616459 · COMPLETED
Trial details
- NCT number
- NCT01616459
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-11
- Primary completion
- 2013-04-25
- Enrollment
- 953
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.